| 0 (0%) | 04-25 05:21 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.97 | 1-year : | 3.47 |
| Resists | First : | 2.54 | Second : | 2.97 |
| Pivot price | 2.42  |
|||
| Supports | First : | 2.31 | Second : | 2.17 |
| MAs | MA(5) : | 2.39 |
MA(20) : | 2.39 |
| MA(100) : | 2.42 |
MA(250) : | 2.39 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 49.1 |
D(3) : | 50.2 |
| RSI | RSI(14): 50.1 |
|||
| 52-week | High : | 2.7 | Low : | 2.07 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AVAL ] has closed above bottom band by 36.7%. Bollinger Bands are 28% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.41 - 2.43 | 2.43 - 2.44 |
| Low: | 2.33 - 2.35 | 2.35 - 2.36 |
| Close: | 2.38 - 2.4 | 2.4 - 2.42 |
Sun, 21 Apr 2024
Avalanche Biotechnologies (AAVL) Jumps: Stock Adds 6.1% in Session - Yahoo Movies Canada
Wed, 26 Nov 2014
Avalanche Biotechnologies Inc (AAVL), Anacor Pharmaceuticals Inc (ANAC), DBV Technologies, Boulogne-Billancourt ... - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 1,190 (M) |
| Shares Float | 4,010 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0.6 (%) |
| Shares Short | 428 (K) |
| Shares Short P.Month | 461 (K) |
| EPS | 0.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.15 |
| Profit Margin | 6.3 % |
| Operating Margin | 21.4 % |
| Return on Assets (ttm) | 0.7 % |
| Return on Equity (ttm) | 6.9 % |
| Qtrly Rev. Growth | -7 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 15 |
| PEG Ratio | 0 |
| Price to Book value | 0.46 |
| Price to Sales | 2.43894e+008 |
| Price to Cash Flow | -3.05455e+008 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|